Cargando…

Human Neutrophil Peptide 1 Limits Hypercholesterolemia-induced Atherosclerosis by Increasing Hepatic LDL Clearance

Increases in plasma LDL-cholesterol have unequivocally been established as a causal risk factor for atherosclerosis. Hence, strategies for lowering of LDL-cholesterol may have immediate therapeutic relevance. Here we study the role of human neutrophil peptide 1 (HNP1) in a mouse model of atheroscler...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paulin, Nicole, Döring, Yvonne, Kooijman, Sander, Blanchet, Xavier, Viola, Joana R., de Jong, Renske, Mandl, Manuela, Hendrikse, Jeffrey, Schiener, Maximilian, von Hundelshausen, Philipp, Vogt, Anja, Weber, Christian, Bdeir, Khalil, Hofmann, Susanna M., Rensen, Patrick C.N., Drechsler, Maik, Soehnlein, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5474437/ https://www.ncbi.nlm.nih.gov/pubmed/28111237 http://dx.doi.org/10.1016/j.ebiom.2017.01.006

Ejemplares similares

Evaluation of the BDCA2-DTR Transgenic Mouse Model in Chronic and Acute Inflammation
por: Mandl, Manuela, et al.
Publicado: (2015)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia
por: Puntoni, Mariarita, et al.
Publicado: (2011)

Atherosclerotic Plaque Destabilization in Mice: A Comparative Study
por: Hartwig, Helene, et al.
Publicado: (2015)

ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia—Brief Report
por: Reeskamp, Laurens F., et al.
Publicado: (2021)

Functional alterations of myeloid cell subsets in hyperlipidaemia: relevance for atherosclerosis
por: Soehnlein, Oliver, et al.
Publicado: (2009)

HELP LDL Apheresis Reduces Plasma Pentraxin 3 in Familial Hypercholesterolemia
por: Zanetti, Michela, et al.
Publicado: (2014)

Impact of selective LDL apheresis on serum chemerin levels in patients with hypercholesterolemia
por: Varga, Viktória E., et al.
Publicado: (2016)

Association of Achilles tendon thickness and LDL-cholesterol levels in patients with hypercholesterolemia
por: Wang, Bei, et al.
Publicado: (2018)

Aspirin, but Not Tirofiban Displays Protective Effects in Endotoxin Induced Lung Injury
por: Tilgner, Jessica, et al.
Publicado: (2016)

Clearance and Utilization of Dicarbonyl-Modified LDL in Monkeys and Humans
por: Lankin, Vadim Z., et al.
Publicado: (2023)

The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia
por: Korneva, Victoria, et al.
Publicado: (2022)

LDL apheresis in a woman with severe heterozygous familial hypercholesterolemia. Late, but not too late
por: Mickiewicz, Agnieszka, et al.
Publicado: (2015)

Prevalence and Impact of Apolipoprotein E7 on LDL Cholesterol Among Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2021)

A genetic variant in the LDLR promoter is responsible for part of the LDL-cholesterol variability in primary hypercholesterolemia
por: De Castro-Orós, Isabel, et al.
Publicado: (2014)

Hypercholesterolemia-induced increase in plasma oxidized LDL abrogated pro angiogenic response in kidney grafts
por: Kerforne, Thomas, et al.
Publicado: (2019)

Prevalence of Hypercholesterolemia, High LDL, and Low HDL in Iran: A Systematic Review and Meta-Analysis
por: Akbartabar Toori, Mehdi, et al.
Publicado: (2018)

Advancing Prediction of Pathogenicity of Familial Hypercholesterolemia LDL Receptor Commonest Variants With Machine Learning Models
por: Santos, Raul D.
Publicado: (2021)

Sailing the Uncharted Waters of Familial Hypercholesterolemia LDL Receptor Genetic-Related Variants: Land in Sight?
por: Santos, Raul D.
Publicado: (2023)

Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes
por: Soehnlein, Oliver, et al.
Publicado: (2013)

Chemokine Heteromers and Their Impact on Cellular Function—A Conceptual Framework
por: Blanchet, Xavier, et al.
Publicado: (2023)

Mutation G805R in the transmembrane domain of the LDL receptor gene causes familial hypercholesterolemia by inducing ectodomain cleavage of the LDL receptor in the endoplasmic reticulum
por: Strøm, Thea Bismo, et al.
Publicado: (2014)

Daily White kwao krua dietary supplement alleviates LDL oxidative susceptibility, plasma LDL level and improves vasculature in a hypercholesterolemia rabbit model
por: Ratanachamnong, Piyanee, et al.
Publicado: (2020)

The genetics of familial hypercholesterolemia and emerging therapies
por: Vogt, Anja
Publicado: (2015)

Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART)
por: Mata, Nelva, et al.
Publicado: (2011)

Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher
por: Ginsberg, Henry N., et al.
Publicado: (2016)

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
por: Climent, Elisenda, et al.
Publicado: (2017)

Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
por: Dlouha, Dana, et al.
Publicado: (2023)

Hypercholesterolemia Impairs Clearance of Neutrophil Extracellular Traps and Promotes Inflammation and Atherosclerotic Plaque Progression
por: Dhawan, Umesh Kumar, et al.
Publicado: (2021)

Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice
por: Kooijman, Sander, et al.
Publicado: (2015)

Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation
por: Scicali, Roberto, et al.
Publicado: (2019)

Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
por: Šálek, Tomáš, et al.
Publicado: (2023)

CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL
por: Bartuzi, Paulina, et al.
Publicado: (2016)

Amino acid starvation‐induced LDLR trafficking accelerates lipoprotein endocytosis and LDL clearance
por: Chen, Ye, et al.
Publicado: (2022)

Chronobiology and Chronotherapy of Osteoporosis
por: Winter, Elizabeth M, et al.
Publicado: (2021)

LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase
por: Filippov, Sergey, et al.
Publicado: (2014)

High doses of garlic extract significantly attenuated the ratio of serum LDL to HDL level in rat-fed with hypercholesterolemia diet
por: Ebrahimi, Tahereh, et al.
Publicado: (2015)

Plant sterols–enriched diet decreases small, dense LDL-cholesterol levels in children with hypercholesterolemia: a prospective study
por: Garoufi, Anastasia, et al.
Publicado: (2014)

Prevalence, self-awareness, and LDL cholesterol levels among patients highly suspected as familial hypercholesterolemia in a Japanese community
por: Tada, Hayato, et al.
Publicado: (2020)

LDL‐cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid‐lowering therapy
por: Hamasaki, Masato, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dcdlq1kmg9tq3grholnfjeb5hk